Who We Are
Our Global Vision
5
Continents with BeiGene locations
45
Countries and regions with clinical trials planned or enrolled
140+
Clinical trials initiated across the globe
40+
Global office locations with exponential headcount growth in the U.S. and EU
Our People
Nearly 11,000
Employees working across the globe
1,100+
Highly-credentialed scientists with a proven track record of innovative medicine development
Our Science
20,000+
Patients enrolled in our clinical trials
70+
Markets with regulatory approval for three internally developed medicines
80%
Of the world’s cancer addressed by our prolific oncology pipeline
Mission
Build the first next-generation oncology company – one that expands the highest quality therapies to more people around the world – through courage, persistent innovation, and challenging the status quo.
Vision
Transform the biotechnology industry, creating impactful medicines that will be affordable and accessible to far more cancer patients around the world.
“
We have an organization full of wonderful, talented and passionate people; and I think one of the things that you will realize and recognize is, you know we really believe that we can change the world and we believe we’re doing something that’s special.
”
–
John V. Oyler, Co-Founder, Chairman and CEO
Values
Patients First. Stand up for more affordable medicines for patients everywhere and improve global health and well-being.
Bold Ingenuity. Challenge the status quo to deliver science once thought to be impossible and make bold commitments and deliver against them.
Collaborative Spirit. Foster superior, non-hierarchical teamwork and respect individual differences.
Driving Excellence. Make a lasting impact in the world and have a sense of urgency and agility to follow the science and deliver for patients while maintaining integrity.
